GlassScriptPhysician profile
Jeanwoo Yoo
NPI 1255836219
$21,151.85
in general payments reported to CMS, 2019-2025
19 companies · $7,256 in 2025
The $7,256 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $197 · 2023: $754 · 2024: $13K · 2025: $7,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $13K · Food and Beverage: $6,672 · Education: $1,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,842.74 |
| Food and Beverage | $6,672.40 |
| Education | $1,439.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,809.63 | 2024-2025 | Ensite, Ensite Precision, Gallant |
| Boston Scientific Corporation | $4,775.94 | 2024-2025 | Versacross Access Solution, Resonate El Icd Vr, Watchman Flx |
| Biosense Webster, INC. | $3,720.09 | 2024-2025 | Carto 3, Nuvision Ice Catheter, Octaray Mapping Catheter |
| Medical Device Business Services, INC. | $3,058.94 | 2024 | Carto 3 |
| Biotronik INC. | $2,455.59 | 2023-2024 | Solia, Pamira, Selectra |
| Medtronic, INC. | $926.85 | 2023-2025 | Micra, Selectsecure, Evera Mri Xt Dr Surescan |
| Abiomed | $303.45 | 2024 | Impella |
| Novartis Pharmaceuticals Corporation | $208.77 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.47 | 2022 | |
| Baxter Healthcare | $149.34 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| W. L. Gore & Associates, INC. | $138.24 | 2024 | Gore Cardioform Septal Occluder |
| Astrazeneca Pharmaceuticals LP | $121.60 | 2024 | Wainua |
| E.R. Squibb & Sons, L.L.C. | $115.20 | 2023 | Camzyos |
| Lantheus Medical Imaging, INC. | $58.21 | 2024 | |
| Zimmer Biomet Holdings, INC. | $37.79 | 2025 | Advantagerib |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $22.12 | 2024 | |
| Alnylam Pharmaceuticals INC. | $20.08 | 2024 | Onpattro |
| Janssen Pharmaceuticals, INC | $16.95 | 2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $15.59 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanwoo Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.